1. Neuraminidase inhibitors for influenza;Moscona;N Engl J Med,2005
2. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802;He;Clin Pharmacokinet,1999
3. World Health Organization. Clinical management of human infection with avian influenza A (H5N1) virus. Geneva, Switzerland: WHO; 2007. http://www.who.int/csr/disease/avian_influenza/guidelines/ClinicalManagement07.pdf [accessed 21 December 2009].
4. Update on avian influenza A (H5N1) virus infection in humans;Abdel-Ghafar;N Engl J Med,2008
5. World Health Organization. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. Geneva, Switzerland: WHO; 2009. http://www.who.int/entity/csr/resources/publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf [accessed 1 September 2009].